(Q39084400)

8 September 2017

title

Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer (English)

1 reference

8 September 2017

1 reference

1 reference

Jinming Li

1

1 reference

8 September 2017

Yanli Sun

2

1 reference

8 September 2017

Tingting Jia

3

1 reference

8 September 2017

Rui Zhang

4

1 reference

8 September 2017

Kuo Zhang

5

1 reference

8 September 2017

Lunan Wang

6

1 reference

8 September 2017

language of work or name

English

0 references

publication date

8 October 2013

1 reference

International Journal of Cancer

8 September 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

8 September 2017

volume

134

1 reference

8 September 2017

issue

7

1 reference

8 September 2017

page(s)

1683-1694

1 reference

8 September 2017

cites work

Cancer statistics, 2013

1 reference

Is there a role for immune checkpoint blockade with ipilimumab in prostate cancer?

21 January 2018

1 reference

Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer

21 January 2018

1 reference

Serum antibodies to blood group A predict survival on PROSTVAC-VF.

21 January 2018

1 reference

DNA vaccines for the treatment of prostate cancer

21 January 2018

1 reference

An Artificial PAP Gene Breaks Self-tolerance and Promotes Tumor Regression in the TRAMP Model for Prostate Carcinoma

21 January 2018

1 reference

Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect

21 January 2018

1 reference

Direct gene transfer into mouse muscle in vivo

21 January 2018

1 reference

21 January 2018

1 reference

Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA.

21 January 2018

1 reference

Cancer therapy using a self-replicating RNA vaccine

21 January 2018

1 reference

Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA.

21 January 2018

1 reference

Armored long RNA controls or standards for branched DNA assay for detection of human immunodeficiency virus type 1.

21 January 2018

1 reference

Thermal Stability of RNA Phage Virus-Like Particles Displaying Foreign Peptides

21 January 2018

1 reference

The use of Armored RNA as a multi-purpose internal control for RT-PCR.

21 January 2018

1 reference

Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles

21 January 2018

1 reference

A new RNA vaccine platform based on MS2 virus-like particles produced in Saccharomyces cerevisiae

21 January 2018

1 reference

HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase

21 January 2018

1 reference

DNA vaccine encoding prostatic acid phosphatase (PAP) elicits long-term T-cell responses in patients with recurrent prostate cancer

21 January 2018

1 reference

Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy

21 January 2018

1 reference

Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines

21 January 2018

1 reference

T cell profiling reveals high CD4+CTLA-4 + T cell frequency as dominant predictor for survival after prostate GVAX/ipilimumab treatment

21 January 2018

1 reference

Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen

21 January 2018

1 reference

Transformation of yeast by lithium acetate/single-stranded carrier DNA/polyethylene glycol method

21 January 2018

1 reference

Preparation of a chimeric armored RNA as a versatile calibrator for multiple virus assays

21 January 2018

1 reference

Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype

21 January 2018

1 reference

Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants

21 January 2018

1 reference

Xenogeneic human p53 DNA vaccination by electroporation breaks immune tolerance to control murine tumors expressing mouse p53.

21 January 2018

1 reference

Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer.

21 January 2018

1 reference

Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients

21 January 2018

1 reference

RNA melanoma vaccine: induction of antitumor immunity by human glycoprotein 100 mRNA immunization.

21 January 2018

1 reference

Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity.

21 January 2018

1 reference

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

21 January 2018

1 reference

Virus-like particles induce robust human T-helper cell responses

21 January 2018

1 reference

Aerosol delivery of virus-like particles to the genital tract induces local and systemic antibody responses

21 January 2018

1 reference

A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28482

1 reference

8 September 2017

1 reference